Stockscreener 앱 받기
110.50
0.75%
-0.75
전일 마감가:
$111.25
열려 있는:
$110.04
하루 거래량:
2.41M
Relative Volume:
0.21
시가총액:
$191.21B
수익:
$46.59B
순이익/손실:
$5.41B
주가수익비율:
35.72
EPS:
3.0938
순현금흐름:
$7.38B
1주 성능:
+1.65%
1개월 성능:
+9.67%
6개월 성능:
-1.64%
1년 성능:
-16.19%
1일 변동 폭
$109.35
$111.41
1주일 범위
$107.50
$112.47
52주 변동 폭
$81.97
$137.49
애보트 래버러토리스 Stock (ABT) Company Profile
명칭
Abbott Laboratories
전화
(224) 667-6100
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Compare ABT vs SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
110.50 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
333.77 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
91.00 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.81 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.78 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-22 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2025-10-10 | 개시 | The Benchmark Company | Buy |
| 2025-07-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-06-16 | 개시 | Leerink Partners | Market Perform |
| 2024-10-08 | 개시 | Oppenheimer | Outperform |
| 2024-09-19 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-21 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | 재확인 | Barclays | Overweight |
| 2023-04-20 | 재확인 | Bernstein | Outperform |
| 2023-04-20 | 재확인 | JP Morgan | Overweight |
| 2023-04-20 | 재확인 | Raymond James | Outperform |
| 2023-04-20 | 재확인 | UBS | Buy |
| 2023-04-20 | 재확인 | Wolfe Research | Underperform |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-10-26 | 개시 | Mizuho | Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-27 | 재확인 | Credit Suisse | Outperform |
| 2022-01-27 | 재확인 | Morgan Stanley | Overweight |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | UBS | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-27 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-01-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-06-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-02-07 | 재확인 | BofA/Merrill | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-11-30 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-01-30 | 재확인 | Citigroup | Neutral |
| 2018-01-25 | 재확인 | Stifel | Buy |
| 2018-01-25 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-10-19 | 재확인 | Stifel | Buy |
모두보기
애보트 래버러토리스 주식(ABT)의 최신 뉴스
Recent Report Shows That Rep. Richard Dean Dr McCormick Sold Up to $375K Worth of Abbott Laboratories Sto - benzinga.com
HM Payson & Co. Sells 15,789 Shares of Abbott Laboratories $ABT - MarketBeat
Cidel Asset Management Inc. Sells 184,792 Shares of Abbott Laboratories $ABT - MarketBeat
Fairvoy Private Wealth LLC Has $361,000 Stock Position in Abbott Laboratories $ABT - MarketBeat
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Sells 20,339 Shares of Abbott Laboratories $ABT - MarketBeat
Fifth Third Wealth Advisors LLC Decreases Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Asio Capital LLC Buys Shares of 37,689 Abbott Laboratories $ABT - MarketBeat
Park National Corp OH Lowers Stake in Abbott Laboratories $ABT - MarketBeat
Matrix Asset Advisors Inc. NY Invests $4.29 Million in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories Revenue Breakdown – AQUISUK:ABLD - TradingView
Can Abbott Laboratories (ABT)’s Lingo Partnership With Alphabet (GOOG) Unlock a New Era of AI-Powered Health? - Yahoo Finance
Court Dismisses Amended Securities Complaint Against Abbott Laboratories - TipRanks
Abbott Opposes Consolidating 23 Spinal Cord Stimulator Injury Lawsuits - Medical Device and Diagnostic industry
Strong Buy Case for Abbott Laboratories (ABT) - Yahoo Finance
Abbott Seeks UK Ban On Chinese Rival's Glucose Monitors - Law360
Thompson Investment Management Inc. Has $1.28 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
Toth Financial Advisory Corp Decreases Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Cox Capital Mgt LLC - MarketBeat
Clark & Stuart Inc Has $3.12 Million Position in Abbott Laboratories $ABT - MarketBeat
Top Abbott Executive Makes Bold Move With Fresh Insider Stock Sale - TipRanks
Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle - Investing.com
Abbott And Google Partner To Bring Lingo Glucose Data Into Google Health App - insights.citeline.com
Google and Abbott Partner to Boost Metabolic Health Insights - Healthcare Digital
What's Backing Abbott's Established Pharmaceuticals Division Growth - The Globe and Mail
Wolfe Cuts Stryker, Backs Abbott in Med-Tech Shift - TradingPedia
Abbott Laboratories (NYSE:ABT) Raised to Outperform at Wolfe Research - MarketBeat
Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating - marketscreener.com
Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More - Yahoo Finance
McCollum Christoferson Group LLC Sells 62,644 Shares of Abbott Laboratories $ABT - MarketBeat
V. M. Manning & CO. Inc. Acquires New Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Acquired by DAVENPORT & Co LLC - MarketBeat
Financial Solutions Advisory Group Inc. Acquires 13,623 Shares of Abbott Laboratories $ABT - MarketBeat
Rep. Mike Kelly Unloads Abbott Laboratories (NYSE:ABT) Shares - MarketBeat
Mike Kelly makes multiple trades including Abbott Laboratories and Disney stocks - Investing.com
Abbott Stock Slips As New Heart Trial Stalls - TipRanks
Abbott Laboratories (ABT) Ties Lingo Glucose Data To AI Health Tools - Yahoo Finance
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
The Abbott Big Ten $1 Million Blood Drive is Back - Sports Illustrated
Abbott, Google Health Join Forces on AI-Powered Metabolic Health - mpo-mag.com
Abbott, Google to combine glucose data with AI coaching - MedTech Dive
What Abbott Laboratories (ABT)'s AI-Powered Google Health Partnership Means For Shareholders - simplywall.st
Every 2 Seconds, Someone in the U.S. Needs Blood as Abbott Drive Returns - Stock Titan
Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis - PR Newswire
Abbott and Google Health partner for glucose monitoring solutions - Yahoo Tech
Abbott Laboratories $ABT Shares Sold by West Branch Capital LLC - MarketBeat
Butensky & Cohen Financial Security Inc. Purchases 9,277 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Labs and Appeals: What Is It Good For (Absolutely Nothing)? - Tax Notes
Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
July Jobs Report Stirs Recession Fears: Why J&J and Abbott May Offer Shelter - finance.biggo.com
Abbott, Mead Must Face Baby Formula Retrial, Mo. Panel Says - Law360
The U.S. Labor Market Is Weakening. These 2 Dividend Stocks Look Built to Weather a Recession - The Motley Fool
애보트 래버러토리스 (ABT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.69%
자본화:
|
볼륨(24시간):